Serial angiography in patients with acute coronary syndromes: effect of antithrombotic therapy on angiographic lesion severity

Heart Lung Circ. 2006 Dec;15(6):378-82. doi: 10.1016/j.hlc.2006.09.001. Epub 2006 Oct 30.

Abstract

Background: Patients presenting with acute coronary syndromes (ACS) commonly have a responsible culprit coronary lesion. There is limited data on the natural history of this culprit lesion in the short term and whether there is a change in morphology of this lesion in the days following presentation. Furthermore, the effect of antithrombotic therapy on this process is unknown.

Methods: Sixty-eight patients presenting with ACS had their diagnostic study performed at our institution and had coronary angioplasty performed a few days later at a different hospital. Culprit lesion characteristics including minimum luminal diameter (MLD) and percentage diameter stenosis were determined on each occasion.

Results: Acute myocardial infarction patients (n=14) had improved culprit lesion characteristics at angioplasty compared to baseline (diameter stenosis 78.9% versus 62.4%, p<0.01). Similarly, patients presenting with unstable angina (UA) or non-ST elevation myocardial infarction (non-STEMI) (n=54) had improved diameter stenosis (78.0% versus 72.7%, p<0.001). The change in MLD was greater in MI patients than UAP/non-STEMI patients (0.6mm versus 0.16mm, p<0.01).

Conclusion: Treatment of ACS patients with aspirin with anticoagulant therapy followed by delayed intervention results in angiographic improvement in lesion severity which may provide a more favourable environment in which to undertake percutaneous coronary intervention.

Publication types

  • Clinical Trial

MeSH terms

  • Aged
  • Angina Pectoris / drug therapy
  • Angina Pectoris / pathology*
  • Angina Pectoris / therapy*
  • Angioplasty, Balloon, Coronary
  • Aspirin / therapeutic use
  • Coronary Angiography
  • Coronary Stenosis / drug therapy
  • Coronary Stenosis / pathology*
  • Drug Therapy, Combination
  • Female
  • Fibrinolytic Agents / pharmacology*
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction / drug therapy
  • Myocardial Infarction / pathology*
  • Myocardial Infarction / therapy*

Substances

  • Fibrinolytic Agents
  • Aspirin